FDA Drug Application (020610) for COLAZAL by VALEANT PHARMS INTL

Back to FDA Applications sponsored by VALEANT PHARMS INTL

Application Number020610
Product Number001
FormCAPSULE;ORAL
Dosage750MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCOLAZAL
Active IngredientBALSALAZIDE DISODIUM

Active IngredientCount
List of drugs with Active Ingredient BALSALAZIDE DISODIUM3


Back to FDA Applications sponsored by VALEANT PHARMS INTL